Clinical and molecular characterisation of 350 patients enrolled in NSGO-CTU-HERO, a Nordic multicentre prospective observational real-world study of patients receiving first-line therapy for newly diagnosed epithelial ovarian cancer (OC)

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Kristine Madsen, Mari Bunkholt Elstrand, Heini J. Lassus, René dePont Christensen, Susanne Malander, Parvin Adimi, Guro Aune, Synnöve M. Staff, Gabriel Lindahl, Anja Ør Knudsen, Vibeke Anett Ingebrigtsen, Anniina Färkkilä
+8 more Maria Bjurberg, Trine Jakobi Nøttrup, Kristina Yvonne Lindemann, Elisabeth Berge Nilsen, Signe Valentin Christoffersen, Rebecca Drivsholm Sand, Maria Rossing, Mansoor Raza Mirza
DOI: 10.1016/j.ijgc.2025.103073
Cited by: 0

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment BRCA gene mutations in cancer Endometrial and Cervical Cancer Treatments

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103073–103073
Publication date
1 February 2026
Language
EN